Literature DB >> 31639413

Propionic acid induced behavioural effects of relevance to autism spectrum disorder evaluated in the hole board test with rats.

Melissa M Meeking1, Derrick F MacFabe2, Jennifer R Mepham1, Kelly A Foley1, Lisa J Tichenoff3, Francis H Boon3, Martin Kavaliers4, Klaus-Peter Ossenkopp5.   

Abstract

Autism spectrum disorders (ASD) are a set of neurodevelopmental disorders characterized by abnormal social interactions, impaired language, and stereotypic and repetitive behaviours. Among genetically susceptible subpopulations, gut and dietary influences may play a role in etiology. Propionic acid (PPA), produced by enteric gut bacteria, crosses both the gut-blood and the blood-brain barrier. Previous research has demonstrated that repeated intracerebroventricular (ICV) infusions of PPA in adult rats produce behavioural and neuropathological changes similar to those seen in ASD patients, including hyperactivity, stereotypy, and repetitive movements. The current study examined dose and time related changes of exploratory and repetitive behaviours with the use of the hole-board task. Adult male Long-Evans rats received ICV infusions twice a day, 4 h apart, of either buffered PPA (low dose 0.052 M or high dose 0.26 M, pH 7.5, 4 μL/infusion) or phosphate buffered saline (PBS, 0.1 M) for 7 consecutive days. Locomotor activity and hole-poke behaviour were recorded daily in an automated open field apparatus (Versamax), equipped with 16 open wells, for 30 min immediately after the second infusion. In a dose dependent manner PPA infused rats displayed significantly more locomotor activity, stereotypic behaviour and nose-pokes than PBS infused rats. Low-dose PPA animals showed locomotor activity levels similar to those of PBS animals at the start of the infusion schedule, but gradually increased to levels comparable to those of high-dose PPA animals by the end of the infusion schedule, demonstrating a dose and time dependent effect of the PPA treatments.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Animal model; Autism spectrum disorders; Gastrointestinal factors; Repetitive behaviours; Short chain fatty-acid

Mesh:

Substances:

Year:  2019        PMID: 31639413     DOI: 10.1016/j.pnpbp.2019.109794

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  7 in total

Review 1.  Understanding Abnormal SMO-SHH Signaling in Autism Spectrum Disorder: Potential Drug Target and Therapeutic Goals.

Authors:  Saloni Rahi; Sidharth Mehan
Journal:  Cell Mol Neurobiol       Date:  2020-11-18       Impact factor: 5.046

Review 2.  The Endocannabinoids-Microbiota Partnership in Gut-Brain Axis Homeostasis: Implications for Autism Spectrum Disorders.

Authors:  Roberto Coccurello; Maria Cristina Marrone; Mauro Maccarrone
Journal:  Front Pharmacol       Date:  2022-06-03       Impact factor: 5.988

3.  Can the Hole-Board Test Predict a Rat's Exploratory Behavior in a Free-Exploration Test?

Authors:  Wojciech Pisula; Klaudia Modlinska; Katarzyna Goncikowska; Anna Chrzanowska
Journal:  Animals (Basel)       Date:  2021-04-09       Impact factor: 2.752

Review 4.  The Human Gut Microbiome as a Potential Factor in Autism Spectrum Disorder.

Authors:  Amani Alharthi; Safiah Alhazmi; Najla Alburae; Ahmed Bahieldin
Journal:  Int J Mol Sci       Date:  2022-01-25       Impact factor: 5.923

5.  Protective Effects of Bee Pollen on Multiple Propionic Acid-Induced Biochemical Autistic Features in a Rat Model.

Authors:  Hanan A Alfawaz; Afaf El-Ansary; Laila Al-Ayadhi; Ramesa Shafi Bhat; Wail M Hassan
Journal:  Metabolites       Date:  2022-06-21

Review 6.  Autism Spectrum Disorder Associated With Gut Microbiota at Immune, Metabolomic, and Neuroactive Level.

Authors:  Enriqueta Garcia-Gutierrez; Arjan Narbad; Juan Miguel Rodríguez
Journal:  Front Neurosci       Date:  2020-10-08       Impact factor: 4.677

Review 7.  Mitochondria May Mediate Prenatal Environmental Influences in Autism Spectrum Disorder.

Authors:  Richard E Frye; Janet Cakir; Shannon Rose; Raymond F Palmer; Christine Austin; Paul Curtin; Manish Arora
Journal:  J Pers Med       Date:  2021-03-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.